Cargando…
Oncogenic Kras(G12D) causes myeloproliferation via NLRP3 inflammasome activation
Oncogenic Ras mutations occur in various leukemias. It was unclear if, besides the direct transforming effect via constant RAS/MEK/ERK signaling, an inflammation-related effect of KRAS contributes to the disease. Here, we identify a functional link between oncogenic Kras(G12D) and NLRP3 inflammasome...
Autores principales: | Hamarsheh, Shaima’a, Osswald, Lena, Saller, Benedikt S., Unger, Susanne, De Feo, Donatella, Vinnakota, Janaki Manoja, Konantz, Martina, Uhl, Franziska M., Becker, Heiko, Lübbert, Michael, Shoumariyeh, Khalid, Schürch, Christoph, Andrieux, Geoffroy, Venhoff, Nils, Schmitt-Graeff, Annette, Duquesne, Sandra, Pfeifer, Dietmar, Cooper, Matthew A., Lengerke, Claudia, Boerries, Melanie, Duyster, Justus, Niemeyer, Charlotte M., Erlacher, Miriam, Blazar, Bruce R., Becher, Burkard, Groß, Olaf, Brummer, Tilman, Zeiser, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7125138/ https://www.ncbi.nlm.nih.gov/pubmed/32246016 http://dx.doi.org/10.1038/s41467-020-15497-1 |
Ejemplares similares
-
Acute Graft-Versus-Host Disease, Infections, Vascular Events and Drug Toxicities Affecting the Central Nervous System
por: Vinnakota, Janaki Manoja, et al.
Publicado: (2021) -
Immune modulatory effects of oncogenic KRAS in cancer
por: Hamarsheh, Shaima’a, et al.
Publicado: (2020) -
Ptch2 loss drives myeloproliferation and myeloproliferative neoplasm progression
por: Klein, Claudius, et al.
Publicado: (2016) -
NLRP3 Inflammasome Activation in Cancer: A Double-Edged Sword
por: Hamarsheh, Shaima'a, et al.
Publicado: (2020) -
Infantile Myelofibrosis and Myeloproliferation with CDC42
Dysfunction
por: Verboon, Jeffrey M., et al.
Publicado: (2020)